* Alembic Pharmaceuticals Limited has converted its branch office in the United Arab Emirates into a Wholly Owned Subsidiary (WOS). * The new WOS is named Alembic Pharmaceuticals Scientific Office L.L.C. * This entity is incorporated in the United Arab Emirates and operates in the Pharmaceuticals industry. * Alembic Pharmaceuticals Limited holds 100% shareholding/control of this new subsidiary. * The cost of acquisition was AED 50,000. * Necessary governmental approval was obtained from the Department of Economic Development, Government of Dubai. * The conversion is not a related party transaction, and the promoter/promoter group has no interest in the transaction. * This intimation concerns a newly incorporated entity, so historical financial details are not applicable.
